Yongneng Zhang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Pulmonary Arterial Hypertension

Top Venues

Science translational medicine

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Areli Lorenzana-Carrillo, Keshav Gopal, Nikole J Byrne, Saymon Tejay, Bruno Saleme, Subhash K Das, Yongneng Zhang, Alois Haromy, Farah Eaton, Michelle Mendiola Pla, Dawn E Bowles, Jason R B Dyck, John R Ussher, Evangelos D Michelakis, Gopinath Sutendra
TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure. Science translational medicine 14 (669) (2022)
Yongneng Zhang, Evangelos D Michelakis
Changing cell fate in the wall of pulmonary arteries. Science translational medicine 14 (643) (2022)
Yongneng Zhang, Evangelos D Michelakis
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast! American journal of respiratory and critical care medicine 204 (2) (2021)
Bruno Saleme, Vikram Gurtu, Yongneng Zhang, Adam Kinnaird, Aristeidis E Boukouris, Keshav Gopal, John R Ussher, Gopinath Sutendra
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity. Science translational medicine 11 (478) (2020)